1. Home
  2. SPT vs PLSE Comparison

SPT vs PLSE Comparison

Compare SPT & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPT
  • PLSE
  • Stock Information
  • Founded
  • SPT 2010
  • PLSE 2014
  • Country
  • SPT United States
  • PLSE United States
  • Employees
  • SPT N/A
  • PLSE N/A
  • Industry
  • SPT Computer Software: Prepackaged Software
  • PLSE Medical/Dental Instruments
  • Sector
  • SPT Technology
  • PLSE Health Care
  • Exchange
  • SPT Nasdaq
  • PLSE Nasdaq
  • Market Cap
  • SPT 1.1B
  • PLSE 1.3B
  • IPO Year
  • SPT 2019
  • PLSE 2016
  • Fundamental
  • Price
  • SPT $23.90
  • PLSE $17.07
  • Analyst Decision
  • SPT Buy
  • PLSE
  • Analyst Count
  • SPT 13
  • PLSE 0
  • Target Price
  • SPT $31.69
  • PLSE N/A
  • AVG Volume (30 Days)
  • SPT 617.7K
  • PLSE 159.2K
  • Earning Date
  • SPT 05-08-2025
  • PLSE 05-08-2025
  • Dividend Yield
  • SPT N/A
  • PLSE N/A
  • EPS Growth
  • SPT N/A
  • PLSE N/A
  • EPS
  • SPT N/A
  • PLSE N/A
  • Revenue
  • SPT $418,413,000.00
  • PLSE N/A
  • Revenue This Year
  • SPT $12.00
  • PLSE N/A
  • Revenue Next Year
  • SPT $12.53
  • PLSE N/A
  • P/E Ratio
  • SPT N/A
  • PLSE N/A
  • Revenue Growth
  • SPT 17.79
  • PLSE N/A
  • 52 Week Low
  • SPT $18.52
  • PLSE $6.66
  • 52 Week High
  • SPT $39.75
  • PLSE $25.00
  • Technical
  • Relative Strength Index (RSI)
  • SPT 64.63
  • PLSE 50.34
  • Support Level
  • SPT $20.34
  • PLSE $15.92
  • Resistance Level
  • SPT $21.84
  • PLSE $17.54
  • Average True Range (ATR)
  • SPT 0.92
  • PLSE 0.93
  • MACD
  • SPT 0.46
  • PLSE -0.08
  • Stochastic Oscillator
  • SPT 86.02
  • PLSE 32.58

About SPT Sprout Social Inc

Sprout Social Inc develops a cloud software that brings together social messaging, data and workflows in a unified system of record, intelligence, and action. It has a centralized, secure and powerful platform that can scale horizontally across an organization to drive maximum business value. The firm generates majority revenue from software subscriptions.

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.

Share on Social Networks: